CLINICAL_TRIALS ClinicalTrials.gov record update

A Response-Adapted Clinical Trial of Weekly Carfilzomib With or Without Rituximab for Waldenström's Macroglobulinemia and Marginal Zone Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03269552
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:26.762264+00:00
Published At: 2020-01-18T00:00:00+00:00
Record Updated At: 2020-01-18
Results Posted At: 2020-01-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Marginal Zone Lymphoma", "Recurrent Marginal Zone Lymphoma", "Recurrent Waldenstrom Macroglobulinemia", "Refractory Marginal Zone Lymphoma", "Refractory Waldenstrom Macroglobulinemia", "Waldenstrom Macroglobulinemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-01-18"
protocolSection.identificationModule.nctId: "NCT03269552"
protocolSection.identificationModule.officialTitle: "A Response-Adapted Clinical Trial of Weekly Carfilzomib With or Without Rituximab for Waldenstr\u00f6m\u0027s Macroglobulinemia and Marginal Zone Lymphoma"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-01-18"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.